trial · primary record
CD19/CD22-CAR-transduced T cells
B-NHL
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 130 |
| Primary completion | 2029-07-01 |
| Primary endpoint | Safety |
| Registry ID | NCT05442515 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:05.380Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05442515
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.